Green Park & Golf Ventures

Type

Venture Capital

Status

Active

Location

Dallas, United States

Total investments

92

Average round size

3M

Portfolio companies

62

Rounds per year

7.08

Lead investments

6

Follow on index

0.33

Exits

10

Stages of investment
Seed
Areas of investment
BiotechnologySoftwareInformation TechnologyArtificial IntelligenceHealth CareHealth DiagnosticsMedical DeviceMedicalLife SciencePharmaceutical

Summary

In 2011 was created Green Park & Golf Ventures, which is appeared as VC. The main department of described VC is located in the Dallas. The fund was located in North America if to be more exact in United States.

The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Green Park & Golf Ventures, startups are often financed by TEXO Ventures, Health Wildcatters, MB Venture Partners. The meaningful sponsors for the fund in investment in the same round are UT Horizon Fund, Mark Cuban, Houston Angel Network. In the next rounds fund is usually obtained by Boston Scientific, William McClelland, UT Horizon Fund.

The fund is generally included in 7-12 deals every year. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. Opposing the other organizations, this Green Park & Golf Ventures works on 18 percentage points less the average amount of lead investments. The higher amount of exits for fund were in 2017. Speaking about the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The common things for fund are deals in the range of 1 - 5 millions dollars. The average startup value when the investment from Green Park & Golf Ventures is 1-5 millions dollars.

Besides them, we counted 1 critical employee of this fund in our database.

We can highlight the next thriving fund investment areas, such as SaaS, Enterprise Software. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Channel Medsystems, Ortho Kinematics, Adient Medical. The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little.

Show more

Investor highlights

Industry focus
Healthcare
Stage focus
Seed
Geo focus
United States
Check size
100K — 1M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
92
Lead investments
6
Exits
10
Rounds per year
7.08
Follow on index
0.33
Investments by industry
  • Health Care (57)
  • Medical (36)
  • Biotechnology (30)
  • Medical Device (21)
  • Software (17)
  • Show 76 more
Investments by region
  • United States (87)
  • Israel (1)
  • Sweden (2)
  • Germany (2)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
11
Avg. valuation at time of investment
4M
Group Appearance index
0.41
Avg. company exit year
8
Avg. multiplicator
0.20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
28 Jun 2021 Application Software, Automotive, Information Services (B2C), Transportation, Hospitality, Ride Sharing Early Stage Venture 45M United States, Texas, Dallas
Noninvasix 04 Feb 2021 Health Care, Medical Device, Life Science Seed 2M United States, Texas, Houston

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.